Evommune CFO awarded 98,946 stock options
Evommune, Inc. reported that Chief Financial Officer Kyle Carver received an employee stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Evommune, Inc. reported that Chief Financial Officer Kyle Carver received an employee stock option grant. The award covers 98,946 shares of common stock at an exercise price of $26.77 per share and expires on April 15, 2036.
According to the vesting terms, one fourth of the option vests on the first anniversary of the grant, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to his continuous service. Following this grant, he holds 98,946 derivative securities directly.
Insider Trade Summary
Grant/Award: 98,946 shares
Grant/Award
1 txn
Insider
Carver Kyle
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 98,946 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 98,946 contracts (Direct)
Footnotes (1)
- F1. One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Option shares granted: 98,946 shares
Exercise price: $26.77 per share
Expiration date: April 15, 2036
+3 more
6 metrics
Option shares granted
98,946 shares
Employee stock option award to CFO on April 16, 2026
Exercise price
$26.77 per share
Strike price for employee stock option
Expiration date
April 15, 2036
Option term for CFO grant
Post-grant derivative holdings
98,946 derivative securities
Total options held directly after transaction
Initial vesting tranche
25% of shares
Vests on first anniversary of grant date
Subsequent vesting schedule
36 monthly installments
Remaining option shares vest monthly after first year
Key Terms
Employee Stock Option (Right to Buy), exercise price, Common Stock, vesting, +1 more
5 terms
Employee Stock Option (Right to Buy) financial
"security_title: "Employee Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "26.7700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vesting financial
"shares subject to the option award shall vest on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Evommune (EVMN) disclose about CFO Kyle Carver’s latest equity grant?
Evommune disclosed that CFO Kyle Carver received an employee stock option for 98,946 shares of common stock. The options have an exercise price of $26.77 per share and represent a routine compensation-related equity award rather than an open-market purchase.
What are the key terms of Kyle Carver’s Evommune (EVMN) stock options?
The option gives CFO Kyle Carver the right to buy 98,946 Evommune shares at an exercise price of $26.77 per share. The award expires on April 15, 2036, setting a long-term window during which he may choose to exercise the options.
How do Kyle Carver’s Evommune (EVMN) stock options vest over time?
One fourth of the granted options vest on the first anniversary of the grant date. The remaining shares vest in 36 equal monthly installments afterward, and all vesting is conditioned on Kyle Carver’s continuous service with Evommune through each vesting date.
Is Kyle Carver’s Evommune (EVMN) option grant an open-market stock purchase?
No, the filing describes a compensation-related stock option grant coded as an acquisition (A), not an open-market purchase. The options are exercisable at $26.77 per share and vest over time rather than reflecting immediate buying of common stock in the market.
How many Evommune (EVMN) derivative securities does Kyle Carver hold after this grant?
Following the grant, the filing shows Kyle Carver holding 98,946 derivative securities directly. These represent options linked to Evommune common stock, providing the right to purchase shares in the future at the fixed exercise price of $26.77 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates